Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Essen Biotech
Hadassah Medical Organization
Baylor College of Medicine
Hoffmann-La Roche
Essen Biotech
Columbia University
University of Kentucky